Case Study: Health Equity in Action- Revolutionizing Gene Therapy Accessibility

Join Dr. Boro Dropulic, a biotech veteran, Co-founder, and Executive Director
of Caring Cross, as he presents groundbreaking case study on how his organization is addressing the prohibitively high costs of advanced therapies like CAR-T and other cellular and gene therapies (CGTs). Through a revolutionary point-of-care manufacturing model, Caring Cross has successfully reduced the cost of these life-saving therapies by up to 90%, making them accessible to underserved populations worldwide. This  session will highlight a replicable model that integrates cutting-edge technology with cost management to achieve health equity on a global scale.